FR2597108B1 - Nouveaux polypeptides, leur procede d'obtention, anticorps monoclonaux specifiques pour ces polypeptides, et utilisation de ces polypeptides - Google Patents

Nouveaux polypeptides, leur procede d'obtention, anticorps monoclonaux specifiques pour ces polypeptides, et utilisation de ces polypeptides

Info

Publication number
FR2597108B1
FR2597108B1 FR868617895A FR8617895A FR2597108B1 FR 2597108 B1 FR2597108 B1 FR 2597108B1 FR 868617895 A FR868617895 A FR 868617895A FR 8617895 A FR8617895 A FR 8617895A FR 2597108 B1 FR2597108 B1 FR 2597108B1
Authority
FR
France
Prior art keywords
polypeptides
monoclonal antibodies
antibodies specific
novel
obtaining same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868617895A
Other languages
English (en)
Other versions
FR2597108A1 (fr
Inventor
Joyce M Zarling
Mohammed Shoyab
Hans Marquardt
Marcia B Hanson
Mario N Lioubin
Thomas Joseph Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of FR2597108A1 publication Critical patent/FR2597108A1/fr
Application granted granted Critical
Publication of FR2597108B1 publication Critical patent/FR2597108B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
FR868617895A 1985-12-20 1986-12-19 Nouveaux polypeptides, leur procede d'obtention, anticorps monoclonaux specifiques pour ces polypeptides, et utilisation de ces polypeptides Expired - Lifetime FR2597108B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (2)

Publication Number Publication Date
FR2597108A1 FR2597108A1 (fr) 1987-10-16
FR2597108B1 true FR2597108B1 (fr) 1991-02-15

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868617895A Expired - Lifetime FR2597108B1 (fr) 1985-12-20 1986-12-19 Nouveaux polypeptides, leur procede d'obtention, anticorps monoclonaux specifiques pour ces polypeptides, et utilisation de ces polypeptides

Country Status (29)

Country Link
JP (1) JP2559035B2 (fr)
KR (1) KR920005920B1 (fr)
CN (1) CN1017626B (fr)
AT (1) AT400444B (fr)
AU (2) AU601168B2 (fr)
BE (1) BE905957A (fr)
CA (1) CA1340296C (fr)
CH (1) CH675727A5 (fr)
CY (1) CY1608A (fr)
DE (2) DE3643428A1 (fr)
DK (1) DK174094B1 (fr)
ES (1) ES2003180A6 (fr)
FI (1) FI91484C (fr)
FR (1) FR2597108B1 (fr)
GB (1) GB2185485B (fr)
GR (1) GR862936B (fr)
HK (1) HK65691A (fr)
HU (1) HU210694B (fr)
IE (1) IE59415B1 (fr)
IL (1) IL81017A (fr)
IT (1) IT1213428B (fr)
LU (1) LU86718A1 (fr)
NL (1) NL8603209A (fr)
NO (1) NO174556C (fr)
NZ (1) NZ218634A (fr)
OA (1) OA08494A (fr)
PT (1) PT83986B (fr)
SE (1) SE505059C2 (fr)
SG (1) SG60891G (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
IL97623A (en) * 1990-03-29 1996-01-19 Bristol Myers Squibb Co Monoclonal antibodies against oncostatin M, their preparation and pharmaceutical preparations containing them
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (fr) * 1990-08-02 1992-02-20 Michael Valentine Agrez Facteur d'elongation de fibroblastes derive des cellules cancereuses du colon humain
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
DK615386A (da) 1987-06-21
LU86718A1 (fr) 1988-07-14
AU639048B2 (en) 1993-07-15
ATA340686A (de) 1995-05-15
SG60891G (en) 1991-08-23
CY1608A (en) 1992-04-03
DE3645095C2 (de) 1993-11-18
NO174556B (no) 1994-02-14
AU601168B2 (en) 1990-09-06
IT1213428B (it) 1989-12-20
AU6776590A (en) 1991-03-14
HUT43103A (en) 1987-09-28
FI91484B (fi) 1994-03-31
GB2185485A (en) 1987-07-22
SE8605459D0 (sv) 1986-12-18
GR862936B (en) 1987-10-28
SE505059C2 (sv) 1997-06-16
BE905957A (fr) 1987-06-17
DK174094B1 (da) 2002-06-10
NO865178L (no) 1987-06-22
PT83986A (en) 1987-01-01
CN86108955A (zh) 1987-12-02
DK615386D0 (da) 1986-12-18
HU210694B (en) 1995-06-28
CH675727A5 (fr) 1990-10-31
CA1340296C (fr) 1998-12-29
KR920005920B1 (ko) 1992-07-24
IE863345L (en) 1987-06-20
GB2185485B (en) 1990-07-04
DE3643428A1 (de) 1987-09-24
AU6660886A (en) 1987-06-25
IL81017A (en) 1993-01-14
FR2597108A1 (fr) 1987-10-16
PT83986B (pt) 1989-07-31
IT8622787A0 (it) 1986-12-19
OA08494A (fr) 1988-07-29
CN1017626B (zh) 1992-07-29
SE8605459L (sv) 1987-06-21
DE3643428C2 (fr) 1990-08-23
FI91484C (fi) 1994-07-11
NZ218634A (en) 1991-06-25
ES2003180A6 (es) 1988-10-16
JP2559035B2 (ja) 1996-11-27
HK65691A (en) 1991-08-23
NO865178D0 (no) 1986-12-19
NL8603209A (nl) 1987-07-16
GB8629997D0 (en) 1987-01-28
FI865156A (fi) 1987-06-21
FI865156A0 (fi) 1986-12-17
NO174556C (no) 1994-05-25
AT400444B (de) 1995-12-27
JPS62236498A (ja) 1987-10-16
KR870005645A (ko) 1987-07-06
IE59415B1 (en) 1994-02-23
IL81017A0 (en) 1987-03-31

Similar Documents

Publication Publication Date Title
FR2522679B1 (fr) Procede pour la production d'anticorps monoclonaux humains
RO91262A (fr) Procede pour la preparation du stearate d'acetylerythromycine
FR2597108B1 (fr) Nouveaux polypeptides, leur procede d'obtention, anticorps monoclonaux specifiques pour ces polypeptides, et utilisation de ces polypeptides
PT86117A (fr) Anticorps monoclonaux antigram (-), procede de preparation et applications
FR2618351B1 (fr) Emulsions gelifiees transparentes et leur procede d'obtention
FR2601455B1 (fr) Nouveaux reactifs biologiques en phase solide et leur procede d'obtention
FR2558471B1 (fr) Procede de preparation d'aspartyl peptides, et nouveaux intermediaires de synthese
RO82682A (fr) Procede pour l'obtention de l'uree
MC1865A1 (fr) Procede d'analyse en phase solide
MA20835A1 (fr) Nouveaux ortho-aminoacides, leur procede d'obtention et leurs applications
FR2588857B1 (fr) Ceramique dielectrique et procede d'obtention de celle-ci
FR2549726B1 (fr) Facteurs augmentant la formation d'anticorps humains et procede pour leur preparation
FR2584418B1 (fr) Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
BE893174A (fr) Nouveaux aminoderives dans position 1 du 1-(3',4'-methylene-dioxyphenyl) propan-2-ol et procede pour leur preparation
PT81194A (fr) Procede pour la preparation de nouveaux hydroxy-thia alcenes
FR2566408B1 (fr) Nouveaux pro-medicaments heterocycliques d'oxicams anti-inflammatoires et leur procede de preparation
RO91889A2 (fr) Procede pour la preparation de l'azobisisobutyronitryle
MC1754A1 (fr) Nouveaux tensioactifs fluores derives de matieres proteiniques:leur procede d'obtention et leur utilisation
RO89209A2 (fr) Procede pour l'obtention de glybenclamide
RO80020A2 (fr) Procede pour l'obtention de la biomasse proteique
RO89670A2 (fr) Procede pour l'obtention du disulfure d'alyle
BE871747A (fr) Joints pour gouttieres et leur procede d'obtention
RO91888A2 (fr) Procede pour l'obtention de l'azobisisobutyronitryle
RO92843A2 (fr) Procede pour l'obtention des masses ceramiques electroisolantes
RO91671A3 (fr) Procede pour l'obtention de tert-butylamine